Epirubicin, Cisplatin, 5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma

AIM: To evaluate the clinical efficacy and safety of epirubicin, cisplatin, and 5-FU combination chemotherapy for the sorafenib-refractory metastatic hepatocellular carcinoma (HCC). METHODS: From April 2009 to June 2012, 31 patients who were diagnosed with metastatic and progressive HCC after sorafe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lee, Ji Eun, Bae, Si Hyun, Choi, Jong Young, Yoon, Seung Kew, You, Young Kyoung, Lee, Myung Ah
Natura: Artigo
Lingua:Inglês
Pubblicazione: Baishideng Publishing Group Co., Limited 2014
Soggetti:
Brief Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3886014/
https://ncbi.nlm.nih.gov/pubmed/24415877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i1.235
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi